Although numerous clinical investigations were initiated to investigate the capacity of G-CSF to prevent adverse left ventricular (LV) remodeling in patients with acute myocardial infarction [68-72], limited studies have tested its application in coronary artery growth. This evidence concerns the gene CSF3 and myocardial infarction.